MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
ZBAO
Zhibao Technology Inc. Class A Ordinary Shares
There isn't enough reported data to score ZBAO yet.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
ZBAO Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| N/A | |
| N/A |
ZBAO's profitability is currently weak. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like ZBAO.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
ZBAO PE Valuation
ZBAO has no meaningful PE right now: it lost money over the past year.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
ZBAO Forward outlook
There aren't enough analyst estimates for ZBAO to show an outlook.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over ZBAO in the latest year-over-year earnings comparison.
ZBAO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2025 | -$14.56 | -541% |
| Q4 2024 | $5.25 | +$21.79 |
| Q2 2024 | $3.30 | +$15.20 |
| Q4 2023 | -$16.54 | -577% |
| Q2 2023 | -$11.90 | -241% |
ZBAO lost $14.56 per share over the past year, a bigger loss than the year before.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
ZBAO has the stronger quarterly revenue trend. Revenue is up 12% for MS versus up 144% for ZBAO.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
ZBAO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $30.9M | +41% |
| Q2 2025 | $19.6M | +31% |
| Q4 2024 | $22M | +74% |
| Q2 2024 | $14.9M | +89% |
| Q4 2023 | $12.6M | +85% |
| Q2 2023 | $7.9M | +2.9% |
| Q1 2023 | $3.8M | +1.7% |
| Q4 2022 | $6.8M | -22% |
ZBAO's revenue has grown year over year for seven quarters in a row: $31M last quarter, up 144% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 2.3% | +12 points |
| Q2 2025 | -44% | +58 points |
| Q4 2024 | 2.6% | +104 points |
| Q2 2024 | 19% | +12 points |
| Q4 2023 | -9.9% | -17 points |
| Q2 2023 | -101% | -114 points |
| Q1 2023 | -101% | -114 points |
| Q4 2022 | 7.1% | +1.5 points |
ZBAO's operating margin was 2.3% last quarter, up 12 points from the same quarter a year ago.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS has the stronger cash trend. Its trailing FCF is down 492% versus its history, compared with ZBAO at down 603%.
ZBAO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2023 | -$32.3M | -$29M |
| Q1 2023 | -$15.5M | -$14M |
| Q4 2022 | $15.3M | +420% |
| Q3 2022 | $15.5M | +934% |
ZBAO's free cash flow was −$34M over the past year, against $14M the year before. Free cash flow isn't a meaningful measure for financial services companies like ZBAO.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
ZBAO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | 1.0x | Very low |
| Q3 2022 | 5.5x | High |
| Q2 2022 | 1.1x | Healthy |
ZBAO's net debt is about a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like ZBAO.
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
ZBAO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.8 | Oversold |
| Stochastic | 0.1 | Oversold |
ZBAO's weekly RSI is 25 (oversold) and its Stochastic is 0 (oversold).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
ZBAO PE vs Financial Services Sector
| Metric | ZBAO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
ZBAO has no meaningful PE right now: it lost money over the past year.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has stronger trend alignment. MS is above 3 of 5 weekly averages versus ZBAO above 0 of 4.
ZBAO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.75 | 88% below |
| 20 week MA | $7.43 | 97% below |
| 50 week MA | $27.9 | 99% below |
| 100 week MA | $43.1 | 100% below |
ZBAO is in a downtrend: it's below all four of its weekly moving averages, and 100% below its 100-week average.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over ZBAO on returns for 2026, with the stronger performance.
ZBAO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $170.0 | $88.0 | -48% |
| 2025 | $88.0 | $44.7 | -49% |
| 2026 YTD | $44.7 | $0.21 | -100% |
ZBAO has finished every year since 2024 lower, and it's down 100% so far in 2026.